Companies

Syntropic develops a non-invasive and non-pharmaceutical treatment for mental health disorders. Through light stimulation, neural remodeling is activated by instructing the immune cells of the brain to support in healing and recovery.

ONCO-Boost, the first product from HEPHAISTOS-Pharma’s platform, is a natural TLR4 agonist that stimulates the patients’ own immune system to strengthen both innate and adaptive immune systems to strengthen their responses against cold tumors.

Batteries are needed to store renewable energy – it's not always windy when you want it to be, and the same applies to the hours of sunshine. Rivus’ idea is for gigantic batteries to be placed at solar and wind farms.

Infrared.city is a platform for intelligent and resilient architecture and construction design powered by Artificial Intelligence. Using simulation prediction models, infrared.city can deliver simulation results at a fraction of the computational time and financial cost. Their state of the art machine learning models provide real-time feedback on the performance of design proposals and can guide climate informed decisions at every step of the process.

subdron is dedicated to transforming underwater inspections through the development of close range navigation for Autonomous Underwater Vehicles (AUVs) and automatized data processing and analysis. By leveraging vanguard hardware technology and artificial intelligence, subdron aims to revolutionize the way underwater structures such as port infrastructure and ship hulls are inspected for damages and biofouling. Their mission is to provide efficient, cost-effective, and environmentally friendly solutions for underwater infrastructure management.

ReCatalyst reduces required platinum in fuel cell catalysts for applications in heavy duty transport, while improving efficiency and durability

VitreaLab is commercializing integrated laser powered photonic devices that will transform displays as we know them. Inspired by quantum photonic technologies, VitreaLab developed its “Quantum Light Engine” which is a light source capable of illuminating AR, VR, and 3D displays with laser light of unprecedented brightness and perfect colour quality while consuming just a fraction of the energy needed by other technologies.

Solgate’s founders combine deep expertise in the biology of solute carriers with unique chemistry-based approaches for accelerated drugging of difficult targets. Current projects are focused on CNS and immunology indications.

Sarcura set out to tackle one of the toughest challenges in advanced medicine: how to manufacture cell therapies at scale. With an interdisciplinary founders team and a research-derived, innovative product for a growing market, they aimed to miniaturize and automate cell therapy production on a chip.

At xista science ventures, we are proud to have supported this journey from its early days, providing capital, infrastructure, and a place in our community. While Sarcura will not continue as a company, it's achievements and people remain part of our ecosystem as a Retired Innovation Pioneer. This

Ribbon Biolabs is a synthetic biology leader driving DNA synthesis beyond the limits of current technologies. With their automated, enzyme-based platform, Ribbon Biolabs can provide synthetic DNA molecules without size or sequence limitations at a high level of accuracy and at unprecedented speed.

Transparency and actionable insights are becoming increasingly important in an interconnected world with complex supply chains and increasing disruption risks. Finding, monitoring and analyzing disruption- and sustainability risks is a tremendous challenge for almost every industry. With its technology, prewave is making supply chains more resilient and sustainable.

Sustainable energy systems need ambitious goals, novel technologies, as well as stringent execution. nista develops an AI-powered data analysis software that they offer as an Energy Efficiency as a Service tool for the energy intensive industry.

G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals against respiratory tract infections. Founded in 2019 by Guido Gualdoni and Johannes Stöckl, the company leverages an innovative host cell-based strategy to overcome respiratory viral infections. This approach is based on a high-impact paper on the interaction of a respiratory virus with the infected cell, which was published by the founders while working at the Medical University of Vienna.

The immune system protects our body against bacteria, viruses and other external threats to our health. Dendritic cells (DCs) play a central role by recognizing such pathogens, processing them and training other immune cells to act against them. At the same time, DCs are also responsible for tolerating the body’s own structures (autoantigens). This complex interaction is achieved by an „orchestra“ of different types of DCs. Cutanos aims to use these mechanisms to develop both vaccines and therapies against autoimmune diseases and allergies.

The cell is at the center of current and future biological science. Future trends require novel technologies to unlock their full potential. The combination of electrodynamics and biotechnology perfectly complements the requirements of emerging industries when it comes to efficient analysis and modulation of biological cells.